How Workforce Integration Challenges Affect the Mental Health of Latin American Immigrants in Canada
Summary
This study examines the experiences of Latin American immigrants who moved to Canada as Federal Skilled Workers but have not yet found work in the profession they were trained for in their home country. It also explores how challenges to workforce integration affect their well-being.
If you decide to take part, you will receive an email invitation and be asked to give your consent. After that, we will arrange an interview of up to two hours, either in person or on Zoom. The interview will be recorded. During the conversation, we will ask open-ended questions about your background, job search experiences, and how these have impacted your mental health and well-being.
Your input will help improve support services for newcomers and shape future research and policies.
You can choose to be interviewed in English or Spanish.
Eligibility
Eligible ages: 18 to 100
Accepts healthy participants: Yes
Inclusion criteria:
1. Identifies as Latin American and has lived in a Latin American country before moving to Canada.
2. Must have come to Canada as a Federal Skilled Worker in the last 10 years.
3. Must not have found a job in Canada that matches their professional credentials and experience from their home country.
Exclusion criteria:
1. People who do not identify as Latin American or who lived in a country outside of Latin America before moving to Canada.
2. Latin Americans who did not immigrate through the Federal Skilled Worker stream.
3. Latin American immigrants who have lived in Canada for more than 10 years.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Ana Fetzer
Principal investigator:
Hieu Ngo
Clinical trial:
No
REB-ID:
REB25-0412